157 related articles for article (PubMed ID: 32738450)
1. p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma.
Luo YD; Fang L; Yu HQ; Zhang J; Lin XT; Liu XY; Wu D; Li GX; Huang D; Zhang YJ; Chen S; Jiang Y; Shuai L; He Y; Zhang LD; Bie P; Xie CM
J Hepatol; 2021 Jan; 74(1):96-108. PubMed ID: 32738450
[TBL] [Abstract][Full Text] [Related]
2. mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma.
Scheller T; Hellerbrand C; Moser C; Schmidt K; Kroemer A; Brunner SM; Schlitt HJ; Geissler EK; Lang SA
Br J Cancer; 2015 Mar; 112(5):841-50. PubMed ID: 25688743
[TBL] [Abstract][Full Text] [Related]
3. Integrated clinical and prognostic analyses of mTOR/Hippo pathway core genes in hepatocellular carcinoma.
Feng T; Chen P; Wang T; Lai C; Yao Y
J Physiol Biochem; 2024 May; 80(2):439-449. PubMed ID: 38468074
[TBL] [Abstract][Full Text] [Related]
4. Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies.
Lu X; Paliogiannis P; Calvisi DF; Chen X
Hepatology; 2021 Jan; 73 Suppl 1(Suppl 1):49-61. PubMed ID: 32394479
[TBL] [Abstract][Full Text] [Related]
5. Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.
Raab S; Gadault A; Very N; Decourcelle A; Baldini S; Schulz C; Mortuaire M; Lemaire Q; Hardivillé S; Dehennaut V; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Panasyuk G; Lefebvre T
Cell Mol Life Sci; 2021 Jul; 78(13):5397-5413. PubMed ID: 34046694
[TBL] [Abstract][Full Text] [Related]
6. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein.
Ortega JF; de Conti A; Tryndyak V; Furtado KS; Heidor R; Horst MA; Fernandes LH; Tavares PE; Pogribna M; Shpyleva S; Beland FA; Pogribny IP; Moreno FS
Oncotarget; 2016 Apr; 7(17):24339-47. PubMed ID: 27013579
[TBL] [Abstract][Full Text] [Related]
7. Chemically engineered mTOR-nanoparticle blockers enhance antitumour efficacy.
Tang H; Dilimulati D; Yang Z; Zhou K; Chen X; Sun R; Wang N; Liang Z; Bian S; Zhao J; Song P; Zheng S; Wang H; Xie H
EBioMedicine; 2024 May; 103():105099. PubMed ID: 38604089
[TBL] [Abstract][Full Text] [Related]
8. HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axis.
Guo JR; He KY; Yuan JL; An W; Yin WT; Li QT; Lu LY; Yang JY; Liu MJ; Li YJ; Zhao Y; Yang Q; Lei XY; Gao F; Zhang L; Wu DH; Li JQ; Zhao ZL; Liu H; Zhu LJ; Xiang XY; Sun QH; Jian YP; Xu ZX
Int J Biol Sci; 2024; 20(7):2640-2657. PubMed ID: 38725843
[TBL] [Abstract][Full Text] [Related]
9. Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Teng CF; Wu HC; Shyu WC; Jeng LB; Su IJ
Cell Transplant; 2017 Mar; 26(3):429-438. PubMed ID: 28195035
[TBL] [Abstract][Full Text] [Related]
10. B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis.
Zhang X; Liu H; Wang H; Zhao R; Lu Q; Liu Y; Han Y; LuluRen ; Pan H; Han W
Cell Mol Life Sci; 2022 Dec; 80(1):8. PubMed ID: 36495345
[TBL] [Abstract][Full Text] [Related]
11. Genetic Suppression of mTOR Rescues Synaptic and Social Behavioral Abnormalities in a Mouse Model of Pten Haploinsufficiency.
Huang WC; Chen Y; Page DT
Autism Res; 2019 Oct; 12(10):1463-1471. PubMed ID: 31441226
[TBL] [Abstract][Full Text] [Related]
12. EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis.
Liu X; Gao X; Yang Y; Yang D; Guo Q; Li L; Liu S; Cong W; Lu S; Hou L; Wang B; Li N
Apoptosis; 2024 May; ():. PubMed ID: 38743191
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC.
Kroh A; Walter J; Fragoulis A; Möckel D; Lammers T; Kiessling F; Andruszkow J; Preisinger C; Egbert M; Jiao L; Eickhoff RM; Heise D; Berndt N; Cramer T; Neumann UP; Egners A; Ulmer TF
Neoplasia; 2023 Dec; 46():100945. PubMed ID: 37976569
[TBL] [Abstract][Full Text] [Related]
14. TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation.
Pelletier CL; Maggi LB; Brady SN; Scheidenhelm DK; Gutmann DH; Weber JD
Cancer Res; 2007 Feb; 67(4):1609-17. PubMed ID: 17308101
[TBL] [Abstract][Full Text] [Related]
15. p53 gene in treatment of hepatic carcinoma: status quo.
Guan YS; La Z; Yang L; He Q; Li P
World J Gastroenterol; 2007 Feb; 13(7):985-92. PubMed ID: 17373730
[TBL] [Abstract][Full Text] [Related]
16. ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling.
Chiang JY; Wei ST; Chang HJ; Chen DC; Wang HL; Lei FJ; Wei KY; Huang YC; Wang CC; Hsieh CH
Br J Cancer; 2024 May; 130(8):1324-1336. PubMed ID: 38347095
[TBL] [Abstract][Full Text] [Related]
17. GPX4 transcriptionally promotes liver cancer metastasis via GRHL3/PTEN/PI3K/AKT axis.
Pan R; Zhao Z; Xu D; Li C; Xia Q
Transl Res; 2024 May; 271():79-92. PubMed ID: 38797432
[TBL] [Abstract][Full Text] [Related]
18. Transaldolase haploinsufficiency in subjects with acetaminophen-induced liver failure.
Oaks Z; Jimah J; Grossman CC; Beckford M; Kelly R; Banerjee S; Niland B; Miklossy G; Kuloglu Z; Kansu A; Lee W; Szonyi L; Banki K; Perl A
J Inherit Metab Dis; 2020 May; 43(3):496-506. PubMed ID: 31769880
[TBL] [Abstract][Full Text] [Related]
19. Increased mTOR activity and metabolic efficiency in mouse and human cells containing the African-centric tumor-predisposing p53 variant Pro47Ser.
Gnanapradeepan K; Leu JI; Basu S; Barnoud T; Good M; Lee JV; Quinn WJ; Kung CP; Ahima R; Baur JA; Wellen KE; Liu Q; Schug ZT; George DL; Murphy ME
Elife; 2020 Nov; 9():. PubMed ID: 33170774
[TBL] [Abstract][Full Text] [Related]
20. mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.
Winans T; Oaks Z; Choudhary G; Patel A; Huang N; Faludi T; Krakko D; Nolan J; Lewis J; Blair S; Lai Z; Landas SK; Middleton F; Asara JM; Chung SK; Wyman B; Azadi P; Banki K; Perl A
J Autoimmun; 2023 Nov; 140():103112. PubMed ID: 37742509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
